Results 261 to 270 of about 58,384 (313)

Correction to: Kidney Week 2024 Abstract Treatment of Recurrent IgA Nephropathy after Kidney Transplant with Delayed-Release Budesonide TH-PO709.

J Am Soc Nephrol
Ebrahimi N, Wongworawat YC, Abdi Pour A, Norouzi S.   +3 more
europepmc   +1 more source

Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

New England Journal of Medicine, 2018
Paul M O'byrne, J Mark Fitzgerald, Eric D Bateman   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial

Lancet, The, 2019
Jo Hardy, Christina Baggott, James Fingleton   +2 more
exaly   +2 more sources

Understanding Lignin Aggregation Processes. A Case Study: Budesonide Entrapment and Stimuli Controlled Release from Lignin Nanoparticles

ACS Sustainable Chemistry and Engineering, 2018
The mechanism of lignin nanoprecipitation and subsequent self-assembly was elucidated by studying generation of lignin nanoparticles (LNPs) from aqueous ethanol.
Mika H Sipponen, Heiko Lange, Mariko Ago
exaly   +2 more sources

Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial

Gastroenterology, 2019
BACKGROUND & AIMS Swallowed topical-acting corticosteroids are recommended as first-line therapy for eosinophilic esophagitis (EoE). Asthma medications not optimized for esophageal delivery are sometimes effective, although given off-label.
Alfredo J Lucendo, Stephan Miehlke, Michael Vieth   +2 more
exaly   +2 more sources

Patch testing of budesonide in Italy: The SIDAPA baseline series experience, 2018–2019

Contact Dermatitis, 2021
Budesonide was included in the European Baseline Series in 2000 as the most suitable marker forcorticosteroid hypersensitivity. In the last two decades, a decreasing trend of budesonide allergy has been observed.
L. Stingeni, R. Marietti, L. Bianchi, F. Guarneri, S. Ferrucci, A. Faraci, C. Foti, P. Romita, C. Patruno, M. Napolitano, R. Gallo, M. Corazza, D. Schena, N. Milanesi, F. Bruni, P. Pigatto, M. Musumeci, E. Martina, V. Piras, M. Tramontana, K. Hansel   +20 more
semanticscholar   +1 more source

Budesonide

Reactions Weekly, 2018
  +7 more sources

Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss

International Forum of Allergy and Rhinology, 2018
Olfactory training (OT) helps many patients with olfactory loss, but unfortunately it is ineffective for a significant number of patients. Budesonide irrigations are widely used to help patients with paranasal sinus inflammation, but have never been ...
Teresa P. Nguyen, Z. Patel
semanticscholar   +1 more source

Budesonide

Reactions Weekly, 1991
  +6 more sources